Characterization of R-[11C]rolipram for PET imaging of phosphodiesterase-4: in vivo binding, metabolism, and dosimetry studies in rats
Célia Lourenço(Centre for Addiction and Mental Health), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Sylvain Houle, Alan A. Wilson(Centre for Addiction and Mental Health)
Cited by 41
Related Papers
Changes in Regional Brain Glucose Metabolism Measured With Positron Emission Tomography After Paroxetine Treatment of Major Depression
|American Journal of Psychiatry|2001|700
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
Imaging Neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [18F]-FEPPA
|Schizophrenia Bulletin|2014|168
<sup>18</sup>F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to <sup>18</sup>F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
|Journal of Nuclear Medicine|2010|154
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [<sup>18</sup>F]FEPPA
|American Journal of Psychiatry|2016|122